About PathAI
PathAI develops artificial intelligence software and digital pathology systems used in diagnostic workflows, clinical research, and drug development. The company provides AI-powered tools that analyze tissue samples and pathology images to support biomarker discovery, disease characterization, and laboratory operations. Its platform includes AISight, a digital pathology image management system used for case review, image analysis, workflow coordination, and integration of AI applications into pathology environments. PathAI also offers laboratory services, pathology data analysis, and machine learning models designed for clinical trials and pharmaceutical research. The company collaborates with healthcare organizations, pathology laboratories, and biopharmaceutical companies to support precision medicine and pathology digitization initiatives. Its technology is applied in areas such as oncology, liver disease research, companion diagnostics, and pathology workflow automation.
Open positions (3)
Company details
Funding
Total raised
$255M
Last stage
Series C
Investors
Founders
Andrew H. Beck
MD from Brown Medical School; completed residency/fellowship in Anatomic Pathology and Molecular Genetic Pathology at Stanford; PhD in Biomedical Informatics from Stanford. Co-founded PathAI in 2016.
LinkedInAditya Khosla
Earned his PhD in Computer Science from MIT. Co-founded PathAI in 2016 alongside Andrew Beck; later departed to become CTO of Iterative Scopes.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.